Option Care Health Inc., the nation's largest independent provider of home and alternate site infusion services, announced its financial results for the second quarter ended June 30, 2025. The company reported net revenue of $1.416 billion, a 15.4% increase from $1.227 billion in the same quarter of 2024. Gross profit rose to $269 million, representing 19.0% of net revenue, compared to $249.4 million or 20.3% of net revenue in the previous year's second quarter. Net income for the quarter was $50.5 million, slightly down from $53 million in the second quarter of 2024, while adjusted net income increased to $67.5 million from $64.9 million. The company also noted an adjusted diluted earnings per share of $0.41, which is a 10.8% rise from $0.37 in the same period last year. Adjusted EBITDA amounted to $114 million, a 5.2% increase from $108.4 million in the second quarter of 2024. Cash provided by operating activities was $90.3 million, a decrease from $195.7 million in the prior year's second quarter. Option Care Health repurchased approximately $50 million of stock during the quarter. Looking ahead, Option Care Health updated its full-year 2025 financial guidance, expecting to generate net revenue between $5.50 billion and $5.65 billion, adjusted diluted earnings per share ranging from $1.65 to $1.72, adjusted EBITDA between $465 million and $475 million, and cash flow from operations of at least $320 million. The company anticipates an effective tax rate of 25% to 27% and net interest expense of approximately $55 million to $60 million.